NO952715D0 - Substituerte 1-(7-klor-4-kinoleinyl)pyrazol-3-karboksamid-N-oksyd-derivater, fremgangsmåte ved fremstilling derav og farmasöytiske preparater som inneholder dem - Google Patents

Substituerte 1-(7-klor-4-kinoleinyl)pyrazol-3-karboksamid-N-oksyd-derivater, fremgangsmåte ved fremstilling derav og farmasöytiske preparater som inneholder dem

Info

Publication number
NO952715D0
NO952715D0 NO952715A NO952715A NO952715D0 NO 952715 D0 NO952715 D0 NO 952715D0 NO 952715 A NO952715 A NO 952715A NO 952715 A NO952715 A NO 952715A NO 952715 D0 NO952715 D0 NO 952715D0
Authority
NO
Norway
Prior art keywords
quinoleinyl
carboxamide
pyrazole
chloro
substituted
Prior art date
Application number
NO952715A
Other languages
English (en)
Other versions
NO952715L (no
Inventor
Robert Boigegrain
Danielle Gully
Francis Jeanjean
Antoine Pradines
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO952715D0 publication Critical patent/NO952715D0/no
Publication of NO952715L publication Critical patent/NO952715L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO952715A 1994-07-08 1995-07-07 Substituerte 1-(7-klor-4-kinoleinyl)pyrazol-3-karboksamid-N-oksyd-derivater, fremgangsmåte ved fremstilling derav og farmasöytiske preparater som inneholder dem NO952715L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408459A FR2722193B1 (fr) 1994-07-08 1994-07-08 Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant

Publications (2)

Publication Number Publication Date
NO952715D0 true NO952715D0 (no) 1995-07-07
NO952715L NO952715L (no) 1996-01-09

Family

ID=9465167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952715A NO952715L (no) 1994-07-08 1995-07-07 Substituerte 1-(7-klor-4-kinoleinyl)pyrazol-3-karboksamid-N-oksyd-derivater, fremgangsmåte ved fremstilling derav og farmasöytiske preparater som inneholder dem

Country Status (17)

Country Link
US (1) US5561234A (no)
EP (1) EP0695747A1 (no)
JP (1) JPH0841051A (no)
KR (1) KR960004341A (no)
CN (1) CN1042533C (no)
AU (1) AU695588B2 (no)
CA (1) CA2153432A1 (no)
FI (1) FI953360A (no)
FR (1) FR2722193B1 (no)
HU (1) HUT73175A (no)
IL (1) IL114500A (no)
NO (1) NO952715L (no)
NZ (1) NZ272525A (no)
PL (1) PL309546A1 (no)
RU (1) RU2145323C1 (no)
TW (1) TW318847B (no)
ZA (1) ZA955673B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0968001B1 (en) * 1997-02-03 2003-11-05 Mallinckrodt Inc. Method for the detection and localization of malignant human pancreatic tumours

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283852A (en) * 1976-01-01 1977-07-13 Christiaens Sa A Pyridine derivatives
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters
JPH02268162A (ja) * 1989-04-10 1990-11-01 Fujisawa Pharmaceut Co Ltd ジフェニルピリジン誘導体
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
JPH0841051A (ja) 1996-02-13
US5561234A (en) 1996-10-01
AU695588B2 (en) 1998-08-20
CN1042533C (zh) 1999-03-17
EP0695747A1 (fr) 1996-02-07
ZA955673B (en) 1996-02-20
FR2722193A1 (fr) 1996-01-12
IL114500A0 (en) 1995-11-27
KR960004341A (ko) 1996-02-23
FI953360A (fi) 1996-01-09
TW318847B (no) 1997-11-01
IL114500A (en) 1999-11-30
HU9502081D0 (en) 1995-09-28
HUT73175A (en) 1996-06-28
RU2145323C1 (ru) 2000-02-10
CN1120042A (zh) 1996-04-10
CA2153432A1 (en) 1996-01-09
AU2486795A (en) 1996-01-18
NZ272525A (en) 1997-02-24
FI953360A0 (fi) 1995-07-07
FR2722193B1 (fr) 1996-10-04
PL309546A1 (en) 1996-01-22
NO952715L (no) 1996-01-09

Similar Documents

Publication Publication Date Title
DK0835246T3 (da) Aromatiske forbindelser og farmaceutiske præparater, der indeholder dem
NO307827B1 (no) Benzoksazol- og pyridinderivater, anvendelse av dem og farmasøytisk preparat inneholdende dem
NO953260L (no) Glycinamid-derivater, fremgangsmåter for fremstilling derav og medisiner som inneholder dem
NO20005430L (no) 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmåter for fremstilling av disse, medisinske preparater inneholdende disse, og mellomprodukter for disse forbindelser
NO981817L (no) Indolin-2-on-derivater, fremgangsmÕte for fremstilling av dem og farmas÷ytiske blandinger inneholdende dem
DK0826673T3 (da) Acetamidderivater, fremgangsmåde til fremstilling deraf og medicinske præparater
NO303388B1 (no) Indolderivater, farmas°ytisk preparat inneholdende dem og mellomprodukter ved fremstilling av dem
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO985671D0 (no) Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte for deres fremstilling og farmas°ytiske preparater som inneholder dem
NO932120D0 (no) Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
DK0839149T3 (da) Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem
NO961000D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
NO960722L (no) Benzazepinderivat, farmasöytisk preparat inneholdende dette, og mellomprodukter for dette
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
NO955320L (no) Substituerte 4-fenyltiazolderivater, fremgangsmåte for fremstilling derav og farmasöytiske blandinger som inneholder dem
NO975076D0 (no) Farmasöytisk preparat som inneholder tiagabinhydroklorid, og fremgangsmåte for dets fremstilling
DK258187A (da) 1-(hydroxystyryl)-5h-2,3-benzodiazepinderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende dem
NO974934D0 (no) 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene
NO20003290L (no) N-fenylamid- og N-pyridylamidderivater, fremgangsmÕte for fremstilling av dem, og farmasøytiske preparater som inneholder dem
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
EE9400148A (et) Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid
DK425384A (da) Acylindol-derivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater som indeholder dem
NO952715D0 (no) Substituerte 1-(7-klor-4-kinoleinyl)pyrazol-3-karboksamid-N-oksyd-derivater, fremgangsmåte ved fremstilling derav og farmasöytiske preparater som inneholder dem
HUT67605A (en) 1-(4-oxo-thiazolidin-2-yliden)-thiosemicarbazide derivatives, pharmaceutical preparations containing them and process for producing them
DK0858459T3 (da) Nye sure pyrazolforbindelser, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler, deres nye anvendelse og farmaceutiske præparater med indhold deraf